Shandong Yanggu Huatai Chemical (300121) Fundamentals 2026 — P/E 20.5x, Revenue Analysis | SniperIQ
Shandong Yanggu Huatai Chemical (300121) is a CN-listed Basic Materials company in Chemicals with a market capitalization of ¥4.0B, trading at ¥9.08 on the SHZ. This SniperIQ fundamentals page covers Shandong Yanggu Huatai Chemical's valuation (P/E 20.5x, P/B 1.1x), profitability (net margin 5.7%), revenue (¥3.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shandong Yanggu Huatai Chemical's market cap?
Shandong Yanggu Huatai Chemical (300121) has a market capitalization of approximately ¥4.0B, trading at ¥9.08 on the SHZ. Market cap moves with the live share price.
What is Shandong Yanggu Huatai Chemical's P/E ratio?
Shandong Yanggu Huatai Chemical's trailing twelve-month P/E ratio is 20.5x, with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Shandong Yanggu Huatai Chemical?
Shandong Yanggu Huatai Chemical runs a net profit margin of 5.7%, a gross margin of 16.8%, and an operating margin of 8.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shandong Yanggu Huatai Chemical generate?
Shandong Yanggu Huatai Chemical reported revenue of ¥3.4B for fiscal year 2025, with net income of ¥197M and earnings per share (EPS) of 0.45. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shandong Yanggu Huatai Chemical pay a dividend?
Shandong Yanggu Huatai Chemical offers a trailing dividend yield of about 1.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shandong Yanggu Huatai Chemical financially healthy?
Shandong Yanggu Huatai Chemical carries a debt-to-equity ratio of 0.16x and a current ratio of 4.37x, with a market beta of 0.48. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shandong Yanggu Huatai Chemical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shandong Yanggu Huatai Chemical (300121) the key facts are: market cap ¥4.0B, P/E 20.5x, revenue ¥3.4B, 52-week range 8.73-17.88. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Shandong Yanggu Huatai Chemical's full fundamentals live
Get Shandong Yanggu Huatai Chemical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.